Digirad Corporation (DRAD) - NASDAQ
  • Fri, Apr. 29, 10:57 AM
    • Digirad (DRAD +5.1%) Q1 results: Revenues: $31.2M (+126.1%); SG&A: $9M (+164.7%); Operating Loss: ($0.6M) (-400.0%); Net Income: $11.6M; EPS: $0.58; Non-GAAP EPS: $0.07 (+250.0%); Quick Assets: $9.7M (-49.2%).
    • 2016 Guidance: Revenues: $125M - 130M; Non-GAAP EBITDA: $17M - $18M; Adjusted EPS: $0.30 - 0.35.
    | Fri, Apr. 29, 10:57 AM
  • Fri, Apr. 29, 8:16 AM
    | Fri, Apr. 29, 8:16 AM
  • Fri, Apr. 29, 5:40 AM
    • Digirad (NASDAQ:DRAD): Q1 EPS of $0.07 beats by $0.04.
    • Revenue of $31.2M (+126.1% Y/Y) beats by $1.2M.
    • Press Release
    | Fri, Apr. 29, 5:40 AM
  • Fri, Feb. 26, 6:33 AM
    • Digirad (NASDAQ:DRAD): Q4 EPS of $0.07 beats by $0.02.
    • Revenue of $15.58M (+10.2% Y/Y) misses by $0.31M.
    • Press Release
    | Fri, Feb. 26, 6:33 AM
  • Mon, Feb. 1, 4:38 PM
    • Digirad (NASDAQ:DRAD) declares $0.05/share quarterly dividend, in line with previous.
    • Forward yield 3.91%
    • Payable Feb. 29; for shareholders of record Feb. 16; ex-div Feb. 11.
    | Mon, Feb. 1, 4:38 PM
  • Dec. 23, 2015, 3:19 PM
    • What looks like a fairly typical hunting expedition by a class-action law firm is enough to send thinly-traded Digirad (DRAD -10.1%) sharply lower.
    • A prescient bull on the stock, Seeking Alpha contributor Dane Capital Management isn't concerned, and sees the selloff as a buying opportunity. Even better, there's a positive catalyst looming as management hopes to close its "highly accretive" DMS Health acquisition prior to year-end. With a week to go, Dane is confident management will deliver.
    • Previously: Digirad acquisition excites a bull (Oct. 14)
    | Dec. 23, 2015, 3:19 PM | 2 Comments
  • Dec. 23, 2015, 12:46 PM
    | Dec. 23, 2015, 12:46 PM | 10 Comments
  • Oct. 30, 2015, 6:11 AM
    • Digirad (NASDAQ:DRAD): Q3 EPS of $0.08 beats by $0.02.
    • Revenue of $15.86M (+14.3% Y/Y) beats by $0.21M.
    | Oct. 30, 2015, 6:11 AM | 2 Comments
  • Oct. 14, 2015, 12:46 PM
    | Oct. 14, 2015, 12:46 PM
  • Oct. 14, 2015, 8:58 AM
    • Headquartered in Fargo, ND, DMS Health has about 250 employees and provides mobile diagnostic imaging and related sales and services to small and regional hospitals across the country, but particularly in the upper Midwest.
    • The company had more than $65M in revenue last year.
    • The $36M all-cash deal is expected to be immediately accretive to Digirad's (NASDAQ:DRAD) adjusted earnings and cash flow. Pro forma annual revenue and adjusted EBITDA for the combined entities should be more than $125M and $17M, respectively. The purchase is expected to close this year.
    • A conference call is set for 11 ET.
    • Presentation slides
    • A bull on Digirad for some time, Dane Capital Management says the deal "looks like a game-changer." DRAD is currently selling at 8.5x enterprise value/EBITDA, is paying $36M, and now expects $17M in EBITDA going forward. At that same 8.5x multiple, this makes the stock worth $6.50 versus last night's close of $4.08. The company's $93M of Federal net operating losses and $28M in state NOLs mean the boosted profits are protected from taxes.
    | Oct. 14, 2015, 8:58 AM
  • Aug. 7, 2015, 6:54 AM
    • Digirad (DRAD -2.3%) Q2 results: Revenues: $15.5M (+6.2%); COGS: $10.8M (+6.9%); Operating Expenses: $3.47M (+0.9%); Operating Income: $1.2M (+50.0%); Net Income: $1.1M (+37.5%); EPS: $0.06 (+50.0%); Quick Assets: $21.7M (-1.4%).
    • 2015 Guidance: Revenues: $61M - 63M; Adjusted EPS: $0.19 - 0.21; Adjusted EBITDA: $6.5M - 6.9M.
    | Aug. 7, 2015, 6:54 AM
  • Aug. 7, 2015, 6:03 AM
    • Digirad (NASDAQ:DRAD): Q2 EPS of $0.06
    • Revenue of $15.5M (+6.2% Y/Y)
    | Aug. 7, 2015, 6:03 AM
  • Jun. 24, 2015, 12:54 PM
    • SA Pro author Dane Capital Management spots a possible double in Digirad (DRAD +7.5%) over the next 18 to 36 months. Even better, an investor gets paid to wait with a 5.3% dividend yield. Even better, Chairman Jeff Eberwein's 10b5-1 insider purchase plan on behalf of his fund, Lone Star Value Investors, likely puts a floor just slightly below the stock's current level.
    • The article is under embargo until early tomorrow morning.
    | Jun. 24, 2015, 12:54 PM | 2 Comments
  • Apr. 30, 2015, 6:10 AM
    • Digirad (NASDAQ:DRAD): Q1 EPS of $0.01
    • Revenue of $13.84M (+6.5% Y/Y)
    | Apr. 30, 2015, 6:10 AM
  • Mar. 6, 2015, 12:45 PM
    | Mar. 6, 2015, 12:45 PM | 2 Comments
  • Mar. 6, 2015, 6:03 AM
    • Digirad (NASDAQ:DRAD): Q4 EPS of $0.05 beats by $0.03.
    • Revenue of $14.1M (+12.6% Y/Y)
    | Mar. 6, 2015, 6:03 AM
Company Description
Digirad Corp. designs and develops diagnostic imaging solutions. It provides in-office nuclear cardiology and ultrasound imaging services; and cardiac event monitoring services to physician practices, hospitals and imaging centers. The company also offers mobile and on-site imaging solutions;... More
Sector: Healthcare
Industry: Medical Appliances & Equipment
Country: United States